Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 284

Boehringer Ingelheim regenerates Agomab

Boehringer Ingelheim Venture Fund has participated in a $23.8m round for the antibody developer spun out of University of Turin.

Apr 16, 2019

Chalmers Ventures strengthens team

Jonas Bergman, Rocio Morales and Nina Röding have joined Chalmers Ventures, the investment and incubator arm of Chalmers University of Technology.

Apr 16, 2019

Cardinal Analytx processes series B

Stanford spinout Cardinal Analytx has raised $20.6m out of a targeted $29.3m, adding to a $6.1m series A round backed by Stanford-StartX Fund in 2017.

Apr 16, 2019

AskBio pops $235m question

Asklepios BioPharmaceutical, based on work by UNC Chapel Hill professors Jude Samulski and Xiao Xiao, has secured $235m in funding co-led by TPG Capital and Vida Ventures.

Apr 16, 2019

Investors load up Astroscale series D to $80m

The space debris removal company has raised another $30m for its series D round from investors including UTokyo Innovation Platform and has now received $132m in total.

Apr 15, 2019

News round up 15 April 2019

A roundup of all the latest news on www.globaluniversityventuring.com for our subscribers.

Apr 15, 2019

OUI appoints trio to board

Lindsay Pearson, Adam Stoten and Liam Dolen have been appointed to Oxford University Innovation's board following the departures of Nicola Blackwood and Giles Kerr.

Apr 15, 2019

Nanology Labs finds Facit for funding

The Toronto oncological MRI agent spinout has been backed by Facit’s Prospects Oncology vehicle, to target applications including the identification and treatment of tumours in the brain.

Apr 12, 2019

Sano Genetics matches up $650,000

Cambridge Enterprise joined Seedcamp and private investors for Sano Genetics’ seed round, proceeds of which will support the company’s data-sharing platform for genomic research.

Apr 12, 2019

Xibus captures $1m

Newly-founded MIT food pathogen sensor spinout Xibus has secured seed funding to develop its technology, which utilises synthetic particles to identify bacterial contamination.

Apr 12, 2019
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here